Randomized phase II-III study of matrix metalloproteinase inhibitor (MMPI) BMS-275291 in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC): NCIC-CTG BR. 18. Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Leighl, NB
  • Shepherd, F
  • Paz-Ares, L
  • Douillard, JY
  • Peschel, C
  • Arnold, Andrew
  • Tu, D
  • Galbraith, S
  • Hann, K
  • Seymour, L

publication date

  • July 15, 2004